Fortnightly review. Male pattern androgenetic alopecia

British Medical Journal

Volumn 317, Issue 7162, 1998, Pages 865-869

  Sinclair, Rodney ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FINASTERIDE; MINOXIDIL; RETINOIC ACID; ANTIHYPERTENSIVE AGENT; ENZYME INHIBITOR;

ARTICLE; BODY IMAGE; HAIR FOLLICLE; HEREDITY; HUMAN; MALE; MALE TYPE ALOPECIA; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL DYSFUNCTION; SKIN ALLERGY; SKIN IRRITATION; SOCIAL PSYCHOLOGY; TOPICAL DRUG ADMINISTRATION; ADOLESCENT; ADULT; ALOPECIA; HAIR; PATHOLOGY; PHYSIOLOGY; REVIEW; TRANSPLANTATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALOPECIA; ANDROGENS; ANTIHYPERTENSIVE AGENTS; ENZYME INHIBITORS; FINASTERIDE; HAIR; HUMANS; MALE; MINOXIDIL;

EID: 0032569307     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7162.865     Document Type: Article

References (36)

1. Randall VA. Androgens and human hair growth. Clin Endocrinol 1994;40:139-57.
2. Hamilton JB. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat 1942;71:451-80.
3. Hamilton JB. Effect of castration in adolescent and young adult males upon further changes in the proportion of bare and hairy scalp. J Clin Endocrinol Metab 1960;20:1309-18.
4. Simpson NB, Barth JH. Hair patterns: hirsutes and androgenetic alopecia. In: Dawber RPR, ed. Diseases of the hair and scalp. Oxford: Blackwell Science, 1997.
5. Hamilton JB. Male pattern hair loss in man: types and incidence. Ann N Y Acad Sci 1951;53:708-28.
6. Setty LR. Hair patterns of the scalp of white and Negro males. Am J Phys Anthropol 1970;33:49-55.
7. Kuhlwein A. Androgene Alopzie vom weiblichen Typ beim Mann. Z Hauthr 1985;60:576-578.
8. Rushton DH, Ramsay ID, Norris MJ, Gilkes JJ. Natural progression of male pattern baldness in young men. Clin Exp Dermatol 1991;16:188-92.
9. Kligman AM. The comparative histopathology of male pattern baldness and senescent baldness. Clin Dermatol 1988;6:108-18.
10. Whiting D. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 1993;28:755-63.
11. Curtois M, Loussouarn G, Horseau C, Grollier JF. Hair cycle and alopecia. Skin Pharmacol 1994;7:84-9.
12. Oliver RF, Jahoda CAB. The dermal papilla and the maintenance of hair growth. In: Rogers GA, Reis PR, Ward KA, Marshall RC, eds. The biology of wool and hair. London: Chapman and Hall, 1989:51-67.
13. Obana NJ, Uno H. Dermal papilla cells in macaque alopecia trigger a testosterone-dependent inhibition of follicular cell proliferation. In: van Neste D, Randall VA, eds. Hair research in the next millennium. Amsterdam: Elsevier, 1996:307-10.
14. Hutchinson PE, Thompson JR. The cross-sectional size and shape of human terminal scalp hair. Br J Dermatol 1997;136:159-65.
15. Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin 1996;14:697-711.
16. Griffin JE, Wilson JD. The resistance syndromes: 5α reductase deficiency, testicular feminisation and related disorders 1989. In: Baudet AI, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989;1919-44.
17. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5α reductase deficiency in man: an inherited from of male psuedohermaphroditism. Science 1974;186:1213-5.
18. Burton JL, Halim MM, Meyrick G, Jeans WD, Murphy D. Male pattern alopecia and masculinity. Br J Dermatol 1979;100:567-71.
19. Norstrom RE. Synchronous balding of scalp and hair bearing grafts of scalp transplanted to the skin of the arm in male pattern baldness. Acta Derm Venereol 1979;59:266-8.
20. Orentreich N. Autografts in alopecias and other selected dermatological conditions. Ann NY Acad Sci 1959;83:462.
21. Randall VA, Thornton MJ, Messenger AG. Cultured dermal papilla cells from androgen-dependent human hair follicles (eg beard) contain more androgen receptors than those from non-balding areas of the scalp. J Endocrinol 1992;133:141-7.
22. Itami S, Kurata S, Takayasu S. 5α reductase activity in cultured dermal papilla cells from beard compared with reticular dermal fibroblasts. J Invest Dermatol 1990;94:150-2.
23. Kuster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 1984;11:921-6.
24. Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and 5α reductase genes. J Invest Dermatol 1998;110:849-53.
25. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992;26:926-31.
26. Cash TF, Butters JW. Poor body image: helping the patient to change. Med Aspects Hum Sexuality 1988;22:67-70.
27. Orentreich D, and Orentreich N. Androgenetic alopecia and its treatment, a historical view. In: Unger WP, ed. Hair transplantation. 3rd ed. New York: Marcel Dekker, 1995:1-33.
28. Hecht A. Hair grower and hair-loss prevention drugs. FDA Consumer, 1985 April 19:1-3.
29. Savin RC. Use of topical minoxidil in the treatment of male pattern baldness. J Am Acad Dermatol 1987;16:696-704.
30. Olsen EA, Weiner MS. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment. J Am Acad Dermatol 1987;17:97-101.
31. Olsen E. Finasteride (1 mg) in the treatment of androgenetic alopecia in men [abstract]. Aust J Dermatol 1997;38:A316.
32. Rushton DH, Norris MJ, Ramsay ID. Topical 0.05% finasteride significantly reduced serum DHT concentrations, but had no effect in preventing the expression of genetic hair loss in men. In:Van Neste D, Randall VA, eds. Hair research for the next millennium. Amsterdam: Elsevier, 1996:359-62.
33. Unger WP. Surgical approach to hair loss. In: Olsen EA, ed. Disorders of hair growth. Diagnosis and treatment. New York: McGraw-Hill, 1994:353-74.
34. Lepaw MI. Complications of implantation of synthetic fibres into scalps for 'hair' replacement: experience with fourteen cases. J Dermatol Surg Oncol 1979;5:201-4.
35. Chen W, Zouboulis CC, Orfanos CA. The 5α reductase system and its inhibitors. Recent development and its perspective in treating androgen dependent skin disorders. Dermatol 1996;193:177-84.
36. Li L, Hoffman RM. The feasibility of targeted selective gene therapy of the hair follicle. Nature Med 1995;1:705-6.